Author:
Jorgensen J H,Redding J S,Howell A W
Abstract
The in vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) was compared with the activities of five other orally absorbable antimicrobial agents against 100 clinical isolates of Haemophilus influenzae. Roxithromycin MICs were generally twofold to fourfold higher than those of erythromycin; the MIC for 90% of the strains for roxithromycin was 8 micrograms/ml.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference10 articles.
1. Barlam T. and H. C. Neu. 1984. In vitro comparison of the activity of RU 28965 a new macrolide with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob. Agents Che-8 8 2-16 2 4 0.5-4 1 1 0.125-2 0.5 0.5 0.25-8
2. s0.25 4 <0.25-16 0.03 0.03 0.007-0.25
3. Erythromycin concentrations in middle ear exudates;Bass J. W.;Pediatrics,1971
4. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU 28965 (a new macrolide), and other agents against enteropathogens;Goossens H.;Antimicrob. Agents Chemother.,1985
5. In vitro evaluation of three new macrolide antimicrobial agents;Jones R. N.;Antimicrob. Agents Chemother.,1983
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献